Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1771 of 6351
-
New laser could ease glaucoma without drops
Disease control OngoingThe objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).
Sponsor: BelkinVision • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Family support program aims to shield hispanic LGBTQ+ teens from drugs and depression
Prevention Recruiting nowThis study will evaluate the effects of a parenting intervention for Hispanic sexual minority youth in preventing/reducing drug use and depressive symptoms. It will also examine whether the intervention improves parent social support for the adolescent, parent acceptance, family …
Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Could a rectal gel save children with severe malaria in remote villages?
Disease control By invitation onlyThe goal of this observational study is to assess whether the giving of rectal artesunate and a three day course of an Artemisinin based Combination Therapy (ACT) to children aged 6 months and ≤ 5 years with severe malaria when referral is not feasible is non inferior to giving o…
Sponsor: Tropical Diseases Research Centre, Zambia • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New therapy aims to retrain the brain to stop fake seizures
Symptom relief Recruiting nowThe purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, epi…
Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Smart pacifier aims to boost speech development in preterm infants
Symptom relief Recruiting nowThe goal of this clinical study is to test a new, novel medical device designed to improve speech sound differentiation among hospitalized preterm infants. The device is designed to be used at an age equivalent to 32 weeks of gestation or older and to integrate readily into clini…
Sponsor: Thrive Neuromedical, LLC • Aim: Symptom relief
Last updated Jun 26, 2026 15:54 UTC
-
New hope for Hard-to-Treat prostate cancer: first human trial launches
Disease control OngoingProstate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide. The purpose of this study is to assess safety, pharmacokinetics, and efficacy of ABBV-969 as a monotherapy. ABBV-969 is an investigational drug bein…
Phase 1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for kids with tough leukemia: oral drug combo enters human testing
Disease control Recruiting nowTo find a recommended dose of ASTX727 (cedazuridine/decitabine) in combination with venetoclax for pediatric patients with relapsed AML.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can online therapy calm heart attack survivors' fears?
Symptom relief Recruiting nowThe aim of this study is to evaluate if an online Cognitive Behavioral Therapy (CBT) protocol customized for patients following Acute Coronary Syndrome (ACS), reduce cardiac anxiety, enhance Quality of Life (QoL), and promote increased physical activity while controlling for care…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 26, 2026 18:21 UTC
-
HIIT may shield breast cancer Survivors' hearts from chemo damage
Disease control OngoingChemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabil…
Sponsor: University of Florida • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New biomarker model aims to reduce unnecessary lung biopsies
Diagnosis OngoingThis is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Virus injection aims to stop melanoma before it spreads
Disease control Recruiting nowThis early-phase study will examine Vusolimogene Oderparepvec, a genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virus, with potential oncolytic, immunostimulating and antineoplastic activities. Upon administration, vusolimogene oderparepvec speci…
Early phase 1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Smart scans guide Ultra-Precise radiation for tough prostate cancers
Disease control Recruiting nowSequential cohort evaluation of ideal timing of imaging and treatment spacing to discern maximal PSMA (Prostate specific membrane antigen) PET (Positron Emission Tomography) response (PSMA-11 68Ga, Illucix) for adaptation of dominant intra-prostatic lesion tumor boost dose
Phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Real-World data shows promise for breast cancer combo therapy
Disease control CompletedThis is a non-interventional, ambispective, observational cohort study describing the real-world safety data of approximately 550 Hormone receptor / Human epidermal growth factor receptor 2 (HR+/HER2-) advanced/metastatic breast cancer patients who have received ribociclib combin…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Texting away UTIs: could a phone platform cut unnecessary antibiotics?
Disease control CompletedThe goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unne…
Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New PET tracer could sharpen detection of aggressive breast cancer
Diagnosis Recruiting nowThis prospective, single-center, open-label study aims to evaluate the safety, biodistribution, and tumor imaging characteristics of the novel ACE1-targeted PET radiotracer 68Ga-DOTA-BPP in patients with confirmed or suspected triple-negative breast cancer (TNBC). Participants wi…
Phase 1 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated Aug 23, 2026 00:00 UTC
-
New drug MGC026 takes on advanced cancers in first human trial
Disease control Recruiting nowThe study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, locally advanced or metastatic solid tumors The study has a dose escalation port…
Phase 1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can targeted brain zaps ease months of Post-Concussion struggles?
Symptom relief Recruiting nowThe goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms could include dizziness, headache, fatigue, brain fog, memory difficulty, sleep disruption, irritability,…
Phase 2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Zapping the brain while talking: a new way to break the worry cycle?
Symptom relief Recruiting nowThis study aims to investigate whether the combination of transcranial Direct Current Stimulation (tDCS) and cognitive-behavioral therapy (CBT) is more effective for treating repetitive negative thinking (RNT) in patients with the symptom of high rumination. High ruminators will …
Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New implant aims to open blocked urinary flow without daily pills
Disease control OngoingThe purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.
Sponsor: ProVerum Medical • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New weekly shot aims to curb obesity in rare genetic disorders
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment
Phase 1/2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC